Adam Raymakers

1.0k total citations
48 papers, 664 citations indexed

About

Adam Raymakers is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Adam Raymakers has authored 48 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Economics and Econometrics, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in General Health Professions. Recurrent topics in Adam Raymakers's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (6 papers) and Economic and Financial Impacts of Cancer (5 papers). Adam Raymakers is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (6 papers) and Economic and Financial Impacts of Cancer (5 papers). Adam Raymakers collaborates with scholars based in Canada, United States and United Kingdom. Adam Raymakers's co-authors include Carlo A. Marra, Larry D. Lynd, Fawziah Marra, Mohsen Sadatsafavi, Don D. Sin, Stuart Peacock, Dean A. Regier, Paddy Gillespie, Sam M. Wiseman and Aaron S. Kesselheim and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Adam Raymakers

43 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Raymakers Canada 15 218 152 129 108 99 48 664
Mark E. Boye United States 18 157 0.7× 141 0.9× 88 0.7× 169 1.6× 100 1.0× 40 851
Ellen Korol United States 9 160 0.7× 130 0.9× 102 0.8× 322 3.0× 68 0.7× 19 751
Mickaël Basson France 5 68 0.3× 142 0.9× 196 1.5× 101 0.9× 40 0.4× 6 527
Yunlei Deng China 8 110 0.5× 216 1.4× 127 1.0× 34 0.3× 31 0.3× 11 878
Andrew J. Admon United States 14 99 0.5× 96 0.6× 124 1.0× 41 0.4× 90 0.9× 40 562
Adina Weinerman Canada 14 106 0.5× 135 0.9× 101 0.8× 53 0.5× 72 0.7× 42 725
Qianwen Zhao China 7 109 0.5× 216 1.4× 127 1.0× 31 0.3× 31 0.3× 7 869
H. Burns United Kingdom 9 93 0.4× 211 1.4× 92 0.7× 139 1.3× 68 0.7× 18 662
Julia Thornton Snider United States 18 124 0.6× 258 1.7× 139 1.1× 74 0.7× 150 1.5× 68 998

Countries citing papers authored by Adam Raymakers

Since Specialization
Citations

This map shows the geographic impact of Adam Raymakers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Raymakers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Raymakers more than expected).

Fields of papers citing papers by Adam Raymakers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Raymakers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Raymakers. The network helps show where Adam Raymakers may publish in the future.

Co-authorship network of co-authors of Adam Raymakers

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Raymakers. A scholar is included among the top collaborators of Adam Raymakers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Raymakers. Adam Raymakers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Yizhuo, et al.. (2025). Breast Reconstruction for Inflammatory Breast Cancer: Improving Patient-Reported Outcomes in a High-Risk Population. Annals of Surgical Oncology. 33(4). 3045–3055.
2.
Raymakers, Adam, et al.. (2025). Pediatric Exclusivity–Associated Revenues and Labeling Changes, 2013-2023. The Journal of Pediatrics. 284. 114660–114660.
3.
Pollard, Samantha, et al.. (2024). Assay-guided treatment sequencing in chronic lymphocytic leukemia (CLL): a cost-effectiveness analysis. Scientific Reports. 14(1). 17294–17294.
4.
Cliff, Edward R. Scheffer, Amar H. Kelkar, David A. Russler‐Germain, et al.. (2023). High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions. American Society of Clinical Oncology Educational Book. 43(43). e397912–e397912. 66 indexed citations
5.
6.
Jenei, Kristina, Adam Raymakers, Arnaud Bayle, et al.. (2023). Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study. The Lancet Oncology. 24(6). 624–635. 25 indexed citations
7.
Bentley, Colene, Sara Izadi‐Najafabadi, Adam Raymakers, & Helen McTaggart‐Cowan. (2022). Qualitative Research Informing a Preference Study on Selecting Cannabis for Cancer Survivor Symptom Management: Design of a Discrete Choice Experiment. Patient. 15(4). 497–507. 1 indexed citations
8.
Pollard, Samantha, Deirdre Weymann, Sarah Wordsworth, et al.. (2022). Defining a Core Data Set for the Economic Evaluation of Precision Oncology. Value in Health. 25(8). 1371–1380. 11 indexed citations
9.
Kandasamy, Sujane, et al.. (2021). Reimagining health services and policy research: Embedding environmental sustainability into our research priorities and practice. SHILAP Revista de lepidopterología. 2. 100011–100011. 2 indexed citations
10.
Jenei, Kristina, Michael Burgess, Stuart Peacock, & Adam Raymakers. (2021). Experiences and perspectives of individuals accessing CAR-T cell therapy: A qualitative analysis of online Reddit discussions. Journal of Cancer Policy. 30. 100303–100303. 9 indexed citations
11.
Raymakers, Adam, Dean A. Regier, Stuart Peacock, & Ciara L. Freeman. (2021). Health-related quality of life data collected in chimeric antigen receptor T-cell (CAR-T) therapy clinical trials. Journal of Cancer Policy. 30. 100304–100304. 7 indexed citations
12.
Jenei, Kristina, Adam Raymakers, Daniel E. Meyers, & Vinay Prasad. (2021). Challenges with sex-specific subgroup analyses in oncology clinical trials for drug approvals between 2015–2020. Journal of Cancer Policy. 30. 100311–100311. 3 indexed citations
13.
Regier, Dean A., et al.. (2020). Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values. Patient. 14(2). 187–196. 8 indexed citations
14.
Raymakers, Adam, Mohsen Sadatsafavi, Don D. Sin, et al.. (2019). Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study. European Respiratory Journal. 53(6). 1801257–1801257. 33 indexed citations
15.
Raymakers, Adam, Paddy Gillespie, Mary Clare O’Hara, Matthew D. Griffin, & Seán F. Dinneen. (2018). Factors influencing health-related quality of life in patients with Type 1 diabetes. Health and Quality of Life Outcomes. 16(1). 27–27. 18 indexed citations
16.
Raymakers, Adam, Nicole Tsao, Carlo A. Marra, Philip J. Clements, & Dinesh Khanna. (2016). Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?. The Journal of Rheumatology. 43(10). 1832–1837. 3 indexed citations
17.
Raymakers, Adam, John R. Mayo, Carlo A. Marra, & Mark Fitzgerald. (2013). Diagnostic Strategies Incorporating Computed Tomography Angiography for Pulmonary Embolism. Journal of Thoracic Imaging. 29(4). 209–216. 14 indexed citations
18.
Bashir, Jamil, Adam Raymakers, Michael H. Yamashita, et al.. (2013). A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: A probabilistic decision analysis model. Heart Rhythm. 10(12). 1761–1767. 5 indexed citations
19.
Marra, Fawziah, et al.. (2012). The Cost Effectiveness of Human Papillomavirus Vaccines. Drugs. 72(5). 715–743. 70 indexed citations
20.
Raymakers, Adam, Mohsen Sadatsafavi, Fawziah Marra, & Carlo A. Marra. (2011). Economic and Humanistic Burden of External Genital Warts. PharmacoEconomics. 30(1). 1–16. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark E. Boye Breakdown of academic impact, for papers by Ellen Korol Breakdown of academic impact, for papers by Mickaël Basson Breakdown of academic impact, for papers by Yunlei Deng Breakdown of academic impact, for papers by Andrew J. Admon Breakdown of academic impact, for papers by Adina Weinerman Breakdown of academic impact, for papers by Qianwen Zhao Breakdown of academic impact, for papers by H. Burns Breakdown of academic impact, for papers by Julia Thornton Snider
Rankless by CCL
2026